Trust CO Of The South Tg Therapeutics, Inc. Transaction History
Trust CO Of The South
- $563 Billion
- Q2 2025
A detailed history of Trust CO Of The South transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Trust CO Of The South holds 10,600 shares of TGTX stock, worth $381,494. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,600
Previous 10,600
-0.0%
Holding current value
$381,494
Previous $418 Million
8.72%
% of portfolio
0.07%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
411Shares Held
87.9MCall Options Held
2.34MPut Options Held
2.01M-
Vanguard Group Inc Valley Forge, PA15.6MShares$562 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$410 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$118 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$102 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.23B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...